Categories: Esports

adidas Celebrates 20 Years of its Iconic TOUR360 Footwear Franchise

  • The commemorative model offers a modern update on the historic version that was first introduced in 2005
  • Available in limited quantities on adidas.com, the adidas app and at select retailers beginning November 6

adidas’ most iconic golf footwear franchise focused on performance and innovation – TOUR360 – is celebrating a major milestone: 20 years. Worn by more than 100 men’s and women’s professional champions along with countless golfers worldwide since 2005, today adidas is commemorating the first TOUR360 model that changed the game with a commemorative silhouette packed with modern technology. It will be available in limited quantities on adidas.com, the adidas app and at select retailers beginning today. 

- Advertisement -

This special model is a like-for-like design inspired by the original introduced in 2005 but combines the best of adidas’ technology of today. The upper features premium leather, LIGHTSTRIKE cushioning in the forefoot with BOOST in the heel, and a TORSION TUNNEL that combines with the 360WRAP and internal gusset to help provide golfers with maximum stability and control. The redesigned outsole features a 7-spike THINTECH traction configuration along with technical secondary lugs to help keep golfers locked in for every swing.

- Advertisement -

Masun Denison, Global Footwear Director of adidas Golf said: “20 years ago, TOUR360 challenged traditions by introducing a bold, athletic, high performing product that looked and performed unlike anything else. Over the next 20 years TOUR360 became an icon and we never changed our mindset; pushing the limits of innovation and performance across more than 10 iterations of the franchise. This celebrates the one that started it all, eliciting some nostalgia and emotion for those who were lucky enough to own and experience that first design.”

- Advertisement -

adidas included subtle callouts to make this 20th anniversary edition something special: an ‘est. 2005’ embossed on the backside of the tongue, a gunmetal top eyelet with the number ‘20’ engraved, and the replica silver logo on the back of the heel as an ode to the first model. Every pair will also come in a special shoe box that commemorates every version of TOUR360 that came before. 

- Advertisement -

The TOUR360 20th Anniversary model is available in limited quantities beginning today on adidas.com, the adidas app, and at select retailers. 

- Advertisement -

About adidas:

- Advertisement -

adidas is a global leader in the sporting goods industry. Headquartered in Herzogenaurach/Germany, the company employs more than 62,000 people across the globe and generated sales of €23.7 billion in 2024. For more information, please visit www.adidas-Group.com.
 

- Advertisement -
TheNews Market

Recent Posts

Crypto News: AlphaPepe Presale Records Surge in Whale Accumulation As Bitcoin Price Prediction Eyes $180,000

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

7 hours ago

Crypto Market News: AlphaPepe Finalizes Tier-1 Exchange Shortlist as XRP Price Prediction Targets $5.00

MONACO, May 16, 2026 (GLOBE NEWSWIRE) -- Crypto market news is turning toward AlphaPepe after…

7 hours ago

Qoder Version 1.0 Released: Full Automation of Code Generation, Verification & Delivery

SINGAPORE, May 16, 2026 (GLOBE NEWSWIRE) -- Qoder officially releases version 1.0, upgrading from an…

7 hours ago

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically…

7 hours ago

ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract…

7 hours ago

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast…

7 hours ago